The Latest Cardiac and Vascular News
DRAPER, Utah–(BUSINESS WIRE)–Xenter, Inc. (Xenter.io) announced the recent unveiling of its groundbreaking dual sensor investigational guidewire for TAVR procedures at the Transcatheter Cardiovascular Therapeutics (TCT) 2023 conference in San Francisco, CA. Xenter introduced the first-of-its-kind wireless guidewire designed for use during transcatheter aortic valve replacement (TAVR) procedures that aims to collect an extensive range of crucial real-time data points to serve as an aortic regu
Xenter Medical Technologies Expands, Focuses Initially on the Development of a New Wireless Vascular Imaging and Physiology Platform, Prepares New Global Platform to Collect and Store Physical Intelligence SALT LAKE CITY–(BUSINESS WIRE)–Following the formation of the Xenter Therapeutics business unit, Xenter, Inc. (XenterMD.com), the first purpose-built medical device-data-drug technologies company, today announced […]
–Xenter Continues Rapid Expansion to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health– SALT LAKE CITY–(BUSINESS WIRE)–On the heels of last week’s announcement of the closing of its $12M Series A offering, Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced the appointment of Scott […]
-Xenter’s Expanding Team of Industry Leaders Poised to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health- SALT LAKE CITY–(BUSINESS WIRE)–Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced the appointment of four additional industry leaders to its Board of Directors and the closing of […]
-Xenter’s next-generation technology advances interventional medicine by integrating functions that formerly required multiple devices- SALT LAKE CITY–(BUSINESS WIRE)–On the heels of its April 7 launch announcement, Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced that James R. Tobin has been appointed to the company’s Board of Directors. Founded […]
